Cargando…

Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes?

OBJECTIVES: To determine if dynamic CT can differentiate local progression from radioactive seed-induced peritumoral reaction (RSIPR) after brachytherapy with iodine-125 radioactive seeds (BIRS) for advanced hepatic malignancies. METHODS: Enhanced CT images of seed-implanted lesions between 2006 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Guanyu, Jiao, Dechao, Peng, Sheng, Chen, Xi, Zhang, Yanling, Lin, Letao, Zhong, Zhihui, Li, Yong, Xu, Kaihao, Zhang, Fujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474341/
https://www.ncbi.nlm.nih.gov/pubmed/35980429
http://dx.doi.org/10.1007/s00330-022-09074-x
_version_ 1784789695896485888
author Chen, Guanyu
Jiao, Dechao
Peng, Sheng
Chen, Xi
Zhang, Yanling
Lin, Letao
Zhong, Zhihui
Li, Yong
Xu, Kaihao
Zhang, Fujun
author_facet Chen, Guanyu
Jiao, Dechao
Peng, Sheng
Chen, Xi
Zhang, Yanling
Lin, Letao
Zhong, Zhihui
Li, Yong
Xu, Kaihao
Zhang, Fujun
author_sort Chen, Guanyu
collection PubMed
description OBJECTIVES: To determine if dynamic CT can differentiate local progression from radioactive seed-induced peritumoral reaction (RSIPR) after brachytherapy with iodine-125 radioactive seeds (BIRS) for advanced hepatic malignancies. METHODS: Enhanced CT images of seed-implanted lesions between 2006 and 2018 were retrospectively evaluated. Hounsfield units of peritumoral parenchyma were measured and assessed quantitatively. The classification, conversion, consequences, and serological indicators during follow-up were recorded and quantified. Statistical differences were analyzed using a Pearson χ(2) test. RESULTS: RSIPR was observed in 201 of 290 (69.3%) lesions (161 patients; median age, 55 years; range, 26–79 years), while local progression occurred in 53 lesions. The low density of local progression was much lower than that of RSIPR (p < 0.001), and the former did not exhibit iso-/high density in the portal or equilibrium phase. Ring-like enhancement in progressive lesions was also quite different from RSIPR. Local progression rate was lower for lesions with RSIPR than for those without RSIPR (14.9% vs 25.8%; p = 0.03), and their doses were different (397.2 Gy vs 120.3 Gy, p < 0.001). CONCLUSIONS: Radioactive seed-induced peritumoral reaction has characteristic manifestations on CT images, which is associated with a higher dose of lesions and lower local progression rate. Notably, the enhancement pattern of local progression was distinct from RSIPR and was clearly distinguishable on dynamic-enhanced CT. KEY POINTS: • Radioactive seed-induced peritumoral reaction after brachytherapy with (125)I seeds for liver malignancies has characteristic manifestations on CT images, which is associated with a higher dose of lesions (397.2 Gy vs 120.3 Gy, p < 0.001), as a focal radiation injury. • Lesions with RSIPR were less likely to develop local progression, while those without RSIPR had a higher rate of local progression (14.9% vs 25.8%; p = 0.03). • The enhancement pattern of local progression after brachytherapy was distinct from radioactive seed-induced peritumoral reaction and was clearly distinguishable on dynamic-enhanced CT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-022-09074-x.
format Online
Article
Text
id pubmed-9474341
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-94743412022-09-16 Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes? Chen, Guanyu Jiao, Dechao Peng, Sheng Chen, Xi Zhang, Yanling Lin, Letao Zhong, Zhihui Li, Yong Xu, Kaihao Zhang, Fujun Eur Radiol Oncology OBJECTIVES: To determine if dynamic CT can differentiate local progression from radioactive seed-induced peritumoral reaction (RSIPR) after brachytherapy with iodine-125 radioactive seeds (BIRS) for advanced hepatic malignancies. METHODS: Enhanced CT images of seed-implanted lesions between 2006 and 2018 were retrospectively evaluated. Hounsfield units of peritumoral parenchyma were measured and assessed quantitatively. The classification, conversion, consequences, and serological indicators during follow-up were recorded and quantified. Statistical differences were analyzed using a Pearson χ(2) test. RESULTS: RSIPR was observed in 201 of 290 (69.3%) lesions (161 patients; median age, 55 years; range, 26–79 years), while local progression occurred in 53 lesions. The low density of local progression was much lower than that of RSIPR (p < 0.001), and the former did not exhibit iso-/high density in the portal or equilibrium phase. Ring-like enhancement in progressive lesions was also quite different from RSIPR. Local progression rate was lower for lesions with RSIPR than for those without RSIPR (14.9% vs 25.8%; p = 0.03), and their doses were different (397.2 Gy vs 120.3 Gy, p < 0.001). CONCLUSIONS: Radioactive seed-induced peritumoral reaction has characteristic manifestations on CT images, which is associated with a higher dose of lesions and lower local progression rate. Notably, the enhancement pattern of local progression was distinct from RSIPR and was clearly distinguishable on dynamic-enhanced CT. KEY POINTS: • Radioactive seed-induced peritumoral reaction after brachytherapy with (125)I seeds for liver malignancies has characteristic manifestations on CT images, which is associated with a higher dose of lesions (397.2 Gy vs 120.3 Gy, p < 0.001), as a focal radiation injury. • Lesions with RSIPR were less likely to develop local progression, while those without RSIPR had a higher rate of local progression (14.9% vs 25.8%; p = 0.03). • The enhancement pattern of local progression after brachytherapy was distinct from radioactive seed-induced peritumoral reaction and was clearly distinguishable on dynamic-enhanced CT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-022-09074-x. Springer Berlin Heidelberg 2022-08-18 2022 /pmc/articles/PMC9474341/ /pubmed/35980429 http://dx.doi.org/10.1007/s00330-022-09074-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Oncology
Chen, Guanyu
Jiao, Dechao
Peng, Sheng
Chen, Xi
Zhang, Yanling
Lin, Letao
Zhong, Zhihui
Li, Yong
Xu, Kaihao
Zhang, Fujun
Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes?
title Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes?
title_full Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes?
title_fullStr Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes?
title_full_unstemmed Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes?
title_short Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes?
title_sort peritumoral abnormalities on dynamic-enhanced ct after brachytherapy for hepatic malignancies: local progression or benign changes?
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474341/
https://www.ncbi.nlm.nih.gov/pubmed/35980429
http://dx.doi.org/10.1007/s00330-022-09074-x
work_keys_str_mv AT chenguanyu peritumoralabnormalitiesondynamicenhancedctafterbrachytherapyforhepaticmalignancieslocalprogressionorbenignchanges
AT jiaodechao peritumoralabnormalitiesondynamicenhancedctafterbrachytherapyforhepaticmalignancieslocalprogressionorbenignchanges
AT pengsheng peritumoralabnormalitiesondynamicenhancedctafterbrachytherapyforhepaticmalignancieslocalprogressionorbenignchanges
AT chenxi peritumoralabnormalitiesondynamicenhancedctafterbrachytherapyforhepaticmalignancieslocalprogressionorbenignchanges
AT zhangyanling peritumoralabnormalitiesondynamicenhancedctafterbrachytherapyforhepaticmalignancieslocalprogressionorbenignchanges
AT linletao peritumoralabnormalitiesondynamicenhancedctafterbrachytherapyforhepaticmalignancieslocalprogressionorbenignchanges
AT zhongzhihui peritumoralabnormalitiesondynamicenhancedctafterbrachytherapyforhepaticmalignancieslocalprogressionorbenignchanges
AT liyong peritumoralabnormalitiesondynamicenhancedctafterbrachytherapyforhepaticmalignancieslocalprogressionorbenignchanges
AT xukaihao peritumoralabnormalitiesondynamicenhancedctafterbrachytherapyforhepaticmalignancieslocalprogressionorbenignchanges
AT zhangfujun peritumoralabnormalitiesondynamicenhancedctafterbrachytherapyforhepaticmalignancieslocalprogressionorbenignchanges